Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hansch

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1982
Parkinson's disease: Cogentin with Sinemet, a better responseW W Tourtellotte, A R Potvin, K Syndulko, et al.
Journal of Medicinal Chemistry|August 1, 1989
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationshipsC D Selassie, Z X Fang, R L Li, et al.
Molecular Pharmacology|December 1, 1989
Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effectsA J Shusterman, A K Debnath, C Hansch, et al.
Advances in Neurology|January 1, 1982
Long-latency event-related potentials in normal aging and dementiaK Syndulko, E C Hansch, S N Cohen, et al.
Archives of Biochemistry and Biophysics|April 15, 1982
The use of crystallography, graphics, and quantitative structure--activity relationships in the analysis of the papain hydrolysis of X-phenyl hippuratesR N Smith, C Hansch, K H Kim, et al.
Biochimica Et Biophysica Acta|August 9, 1991
Separation of electronic and hydrophobic effects for the papain hydrolysis of substituted N-benzoylglycine estersC M Compadre, C Hansch, T E Klein, et al.
Journal of Medicinal Chemistry|February 1, 1984
Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine sC Hansch, B A Hathaway, Z R Guo, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1982
Parkinson's disease: Cogentin with Sinemet, a better responseW W Tourtellotte, A R Potvin, K Syndulko, et al.
Journal of Medicinal Chemistry|August 1, 1989
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationshipsC D Selassie, Z X Fang, R L Li, et al.
Molecular Pharmacology|December 1, 1989
Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effectsA J Shusterman, A K Debnath, C Hansch, et al.
Advances in Neurology|January 1, 1982
Long-latency event-related potentials in normal aging and dementiaK Syndulko, E C Hansch, S N Cohen, et al.
Archives of Biochemistry and Biophysics|April 15, 1982
The use of crystallography, graphics, and quantitative structure--activity relationships in the analysis of the papain hydrolysis of X-phenyl hippuratesR N Smith, C Hansch, K H Kim, et al.
Biochimica Et Biophysica Acta|August 9, 1991
Separation of electronic and hydrophobic effects for the papain hydrolysis of substituted N-benzoylglycine estersC M Compadre, C Hansch, T E Klein, et al.
Journal of Medicinal Chemistry|February 1, 1984
Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine sC Hansch, B A Hathaway, Z R Guo, et al.
Pageof 20